IP26-01: Comparison of Pathologic Characteristics and Salvage Treatment Between MRI Visible and Invisible Clinically Significant Prostate Cancer Recurrences (CSPCaR) Following Primary Partial Gland Cryo-ablation (PPGCA).

IP26-01: Comparison of Pathologic Characteristics and Salvage Treatment Between MRI Visible and Invisible Clinically Significant Prostate Cancer Recurrences (CSPCaR) Following Primary Partial Gland Cryo-ablation (PPGCA).

Saturday, May 16, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!